PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Meuten DJ et al. Hypercalcemia in dogs with adenocarcinoma derived from apocrine glands of the anal sac. Biochemical and histomorphometric investigations. 1983 Lab. Invest. pmid:6300551
Town MH et al. Pharmacological and cardiovascular properties of a hydantoin derivative, BW 245 C, with high affinity and selectivity for PGD2 receptors. 1983 Prostaglandins pmid:6302737
Philips JB and Lyrene RK Persistent pulmonary hypertension and prostaglandin D2. 1983 Prog. Clin. Biol. Res. pmid:6577475
Fukushima M [Development of antineoplastic prostaglandins]. 1983 Gan To Kagaku Ryoho pmid:6577812
Schulman ES et al. Purified human basophils and mast cells: current concepts of mediator release. 1983 Eur J Respir Dis Suppl pmid:6578086
Fitzpatrick FA and Wynalda MA Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. 1983 J. Biol. Chem. pmid:6578214
Juhlin L et al. Effect of infrared irradiation on the recoverable levels of free arachidonic acid and prostaglandins in human forearm skin. 1983 J. Invest. Dermatol. pmid:6578272
Gaetani P et al. [Prostaglandin D2 in subarachnoid hemorrhage. Biological and diagnostic implications]. 1983 Jul-Aug Riv Patol Nerv Ment pmid:6598516
Brus R et al. Effect of prostaglandins on morphine-induced catalepsy in mice. 1983 Sep-Dec Acta Physiol Pol pmid:6679984
Bito LZ Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds. 1984 Exp. Eye Res. pmid:6370708
Barrow SE et al. Measurement of prostaglandin D2 and identification of metabolites in human plasma during intravenous infusion. 1984 Prostaglandins pmid:6441188
Bertelé V et al. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products. 1984 Blood pmid:6426554
Peters SP et al. Arachidonic acid metabolism in purified human lung mast cells. 1984 J. Immunol. pmid:6199420
Gresele P et al. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. 1984 Biochem. Pharmacol. pmid:6430299
Vicenzi E et al. Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid. 1984 Clin. Exp. Immunol. pmid:6432383
Nishi S et al. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release. 1984 Horm. Metab. Res. pmid:6152434
Tynan SS et al. On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs. 1984 Prostaglandins pmid:6087417
Neely SM et al. Mechanism and characteristics of platelet activation by haematin. 1984 Br. J. Haematol. pmid:6383458
Uchizono K [Studies of sleep inducing substance]. 1984 Nippon Rinsho pmid:6384575
Philips JB and Lyrene RK Prostaglandins, related compounds, and the perinatal pulmonary circulation. 1984 Clin Perinatol pmid:6386270
Goetzl EJ Asthma: new mediators and old problems. 1984 N. Engl. J. Med. pmid:6330554
Rao PS et al. Prostaglandin D2 in canine endotoxic shock. Hemodynamic, hematologic, biochemical, and blood gas analyses. 1984 Am. J. Obstet. Gynecol. pmid:6424477
Schick B et al. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1984 J. Immunol. pmid:6425408
Dembinska-Kieć A et al. Formation of leukotriene C4-like material by rat brain tissue. 1984 Eur. J. Pharmacol. pmid:6426980
Kawamura M and Koshihara Y Prostaglandin D2 lowers nuclear DNA polymerase activity in cultured mastocytoma cells. 1984 Prostaglandins pmid:6427850
Vincent JE et al. The effect of 5-(2-chlorobenzyl)-5,6,7,7a-tetrahydro 4H-thieno (3.2-C)-pyridine-2-one hydrochloride (PCR 3787), a metabolite of ticlopidine, on the aggregation of human platelets in vitro and on the aggregation inhibiting action of PGI2 and PGD2. 1984 Prostaglandins Leukot Med pmid:6396655
Weichman BM et al. SK&F 88046: a unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandins F2 alpha and D2 in vitro. 1984 J. Pharmacol. Exp. Ther. pmid:6582266
Higashida H et al. Facilitation of synaptic transmission by prostaglandin D2 at synapses between NG108-15 hybrid and muscle cells. 1984 Brain Res. pmid:6324947
Bertelé V et al. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor. 1984 Thromb. Haemost. pmid:6326343
Chapnick BM Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow. 1984 Am. J. Physiol. pmid:6326595
Gardiner PJ and Browne JL Tussive activity of inhaled PGD2 in the cat and characterisation of the receptor(s) involved. 1984 Prostaglandins Leukot Med pmid:6328541
Zavoico GB and Feinstein MB Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase. 1984 Biochem. Biophys. Res. Commun. pmid:6329175
Imanishi J et al. [Inhibition of the multiplication of human herpes virus I by prostaglandin D2 and the synergistic effect of human leukocyte interferon]. 1984 C. R. Seances Soc. Biol. Fil. pmid:6100083
Pan IQ et al. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. 1984 Br. J. Haematol. pmid:6089860
Nilsson J and Olsson AG Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. 1984 Atherosclerosis pmid:6093830
Mitsuma T and Nogimori T Effects of substance P, angiotensin II, oxotremorine and prostaglandin D2 on thyrotropin secretion in rats. 1984 Horm. Res. pmid:6201427
Ennis M et al. Prostaglandin and histamine release from stimulated rat peritoneal mast cells. 1984 Agents Actions pmid:6203356
Seregi A et al. Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. 1984 Brain Res. pmid:6430471
Ikai K et al. Prostaglandin D2 and prostaglandin D synthetase in mast cell deficient mice. 1984 Prostaglandins pmid:6435183
Holgate ST and Robinson C 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-Prostaglandin I1, (U-60,257) stimulates prostaglandin D2 and inhibits thromboxane B2 release from ionophore challenged human dispersed lung cells. 1984 Br. J. Pharmacol. pmid:6439267
Erman A and Nasjletti A Enhancement of renal medulla prostaglandin synthetase activity by dexamethasone treatment in the rat. 1984 Biochem. Biophys. Res. Commun. pmid:6428405
Holgate ST et al. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. 1984 J. Immunol. pmid:6206153
Schleimer RP et al. Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. 1984 J. Allergy Clin. Immunol. pmid:6208229
Inoué S et al. Differential sleep-promoting effects of five sleep substances nocturnally infused in unrestrained rats. 1984 Proc. Natl. Acad. Sci. U.S.A. pmid:6592612
Inoué S et al. Little sleep-promoting effect of three sleep substances diurnally infused in unrestrained rats. 1984 Neurosci. Lett. pmid:6593603
Peters SP et al. Effect of prostaglandin D2 in modulating histamine release from human basophils. 1984 J. Pharmacol. Exp. Ther. pmid:6198512
Marsden KA et al. The effect of prostaglandin D2 (PGD2) on circulating eosinophils. 1984 Prostaglandins Leukot Med pmid:6593748
Uemura S et al. Inotropic effects of prostaglandin D2 and E1 on the newborn rabbit heart. 1984 Pediatr. Res. pmid:6596550
Heavey DJ et al. Effects of intravenous infusions of prostaglandin D2 in man. 1984 Prostaglandins pmid:6596653
Mahmud I et al. On the identification and biological properties of prostaglandin J2. 1984 Prostaglandins Leukot Med pmid:6597446
Arisawa M et al. Direct suppressive effect of prostaglandin D2 on growth hormone secretion from rat anterior pituitary. 1984 Asia Oceania J Obstet Gynaecol pmid:6598030
Newman JH and Sheller JR Arachidonic acid metabolites in the healthy and diseased lung. 1984 Am. J. Med. Sci. pmid:6091454
Ogorochi T et al. Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. 1984 J. Neurochem. pmid:6427411
Abramovich DR et al. The effect of prostaglandin D2 on the blood vessels of the perfused isolated cotyledon of the human placenta. 1984 Br. J. Pharmacol. pmid:6584189
Kikawa Y et al. 9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. 1984 Proc. Natl. Acad. Sci. U.S.A. pmid:6584883
Sakai T et al. Prostaglandin D2 inhibits the proliferation of human malignant tumor cells. 1984 Prostaglandins pmid:6584941
Imashuku S et al. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma]. 1984 Gan To Kagaku Ryoho pmid:6585182
Nakajima M and Toda N Neuroeffector actions of prostaglandin D2 on isolated dog mesenteric arteries. 1984 Prostaglandins pmid:6587438
Andersen NH and Hartzell CJ High-field 1H NMR studies of prostaglandin H2 and its decomposition pathways. 1984 Biochem. Biophys. Res. Commun. pmid:6587849
Gal D et al. Effect of radiation on prostaglandin production by human bowel in vitro. 1984 Int. J. Radiat. Oncol. Biol. Phys. pmid:6588048
Shimatsu A et al. Prostaglandin D2 stimulates vasoactive intestinal polypeptide release into rat hypophysial portal blood. 1984 Mar-Apr Peptides pmid:6591147
Imashuku S et al. Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma. 1985 Prog. Clin. Biol. Res. pmid:2986176
Makino S [Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy]. 1985 Nippon Rinsho pmid:2989584
Siegl AM and Daly JW Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets. 1985 J Cyclic Nucleotide Protein Phosphor Res pmid:2991349
Förstermann U et al. Studies on the mechanism of central cardiovascular and temperature responses to prostaglandin D2. 1985 Prostaglandins Leukot Med pmid:2991946
Orchard MA et al. Thromboxane synthase inhibition causes re-direction of prostaglandin endoperoxides to prostaglandin D2 during collagen stimulated aggregation of human platelet rich plasma. 1985 Thromb. Res. pmid:3936223
McGuire JC et al. Production of prostaglandin D2 by murine macrophage cell lines. 1985 Prostaglandins pmid:3937182
Lewis RA et al. Pharmacologic regulation of mediator generation and release from the murine bone marrow derived mast cell. 1985 Int. Arch. Allergy Appl. Immunol. pmid:2409010
Norman PS et al. Mediator release after allergic and physical nasal challenges. 1985 Int. Arch. Allergy Appl. Immunol. pmid:2409027
Schleimer RP et al. Role of human basophils and mast cells in the pathogenesis of allergic diseases. 1985 J. Allergy Clin. Immunol. pmid:2410478
Lad PM et al. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils. 1985 Biochim. Biophys. Acta pmid:2411298
Finney MJ et al. Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. 1985 Br. J. Pharmacol. pmid:2411319
Fowler JC et al. Prostaglandins block a Ca2+-dependent slow spike afterhyperpolarization independent of effects on Ca2+ influx in visceral afferent neurons. 1985 Brain Res. pmid:2412652
Levi-Schaffer F et al. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. 1985 J. Immunol. pmid:2413121
Forman MB et al. Increased adventitial mast cells in a patient with coronary spasm. 1985 N. Engl. J. Med. pmid:2413358
Lewis RA and Robin JL Arachidonic acid derivatives as mediators of asthma. 1985 J. Allergy Clin. Immunol. pmid:3926852
Armstrong RA et al. Competitive antagonism at thromboxane receptors in human platelets. 1985 Br. J. Pharmacol. pmid:2580580
Hollingsworth EB and Patrick GA The effects produced by prostaglandin D2 on serotonin turnover and release and tryptophan uptake. 1985 Pharmacol. Biochem. Behav. pmid:2581275
Fox CC et al. Isolation and characterization of human intestinal mucosal mast cells. 1985 J. Immunol. pmid:2582045
Bhattacharya SK et al. Prostaglandin D2 mediated specific increase in rat brain serotonin. 1985 Proc. West. Pharmacol. Soc. pmid:3865228
Walenga RW et al. Re-examination of the assay for plasma prostanoids by solid-phase extraction, and radioimmunoassay. 1985 Prostaglandins Leukot Med pmid:3865240
Okuyama S et al. Redifferentiation of cancer cells: bestatin, estradiol, and prostaglandin D2. 1985 Ann. N. Y. Acad. Sci. pmid:3868328
Okuyama S and Mishina H Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro. 1985 Sci Rep Res Inst Tohoku Univ Med pmid:3870142
Okuyama S and Mishina H Principia of cancer therapy. XI. Prostaglandin D2 induces redifferentiation of M1 leukemia cells in vitro irrespective of bestatin. 1985 Sci Rep Res Inst Tohoku Univ Med pmid:3870143
Murray JJ et al. Prostaglandin D2 is released during acute allergic bronchospasm in man. 1985 Trans. Assoc. Am. Physicians pmid:3870298
Kasukabe T et al. Specific inhibition by prostaglandin D2 and its metabolites of lysozyme synthesis in mouse macrophage-like cell line, Mm-1. 1985 Biochim. Biophys. Acta pmid:3855662
Narumiya S and Fukushima M delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. 1985 Biochem. Biophys. Res. Commun. pmid:3857041
Abbate R et al. Decreased number of PGD2 binding sites on platelets from patients with type IIa hyperlipoproteinemia. 1985 Atherosclerosis pmid:3857047
Watanabe K et al. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. 1985 J. Biol. Chem. pmid:3858278
Gause GE et al. Hemodynamic effects of postpulmonary administration of prostaglandin D2 in fetal animals. 1985 Proc. Soc. Exp. Biol. Med. pmid:3858885
Rocklin RE et al. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2). 1985 J. Immunol. pmid:3160784
Banks RO and Jacobson ED Renal vasodilation with ureteral occlusion and prostaglandins: attenuation by histamine H1 antagonists. 1985 Am. J. Physiol. pmid:2866716
Weinreb RN et al. Prostanoids in rabbit aqueous humor: effect of laser photocoagulation of the iris. 1985 Invest. Ophthalmol. Vis. Sci. pmid:3860488
Costall B et al. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent. 1985 Br. J. Pharmacol. pmid:3862460
Watanabe Y et al. Specific bindings of prostaglandin D2, E2 and F2 alpha in postmortem human brain. 1985 Brain Res. pmid:2994820
Fortini A et al. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets. 1985 Thromb. Res. pmid:3001968
Wasserman SI The mast cell and theophylline in asthma. 1985 Am. J. Med. pmid:3002176
Bushfield M et al. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. 1985 Biochem. J. pmid:3002327
Ichikawa A et al. Up-regulation of prostaglandin D2 receptors by agonist binding to beta-adrenoceptors in rabbit platelets. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3004152
Ueno R et al. Changes of enzymes involved in prostaglandin metabolism and prostaglandin binding proteins in rat brain during development and aging. 1985 J. Neurochem. pmid:3925085